Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1.
Clinical trial NCT05858229 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05858229
- Sponsor
- Sherrif Ibrahim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-16
- Primary completion
- 2025-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.